Question 1

Does Woodline Partners own AMLX stock?

Accepted Answer

Yes. As of its Q2 2026 13F, Woodline Partners holds 846,387 shares of AMLX (Amylyx Pharmaceuticals), worth $15.2M.

Question 2

How many shares of AMLX does Woodline Partners own?

Accepted Answer

As of its Q2 2026 13F, Woodline Partners holds 846,387 shares of AMLX (Amylyx Pharmaceuticals).

Question 3

What is Woodline Partners' AMLX position worth?

Accepted Answer

As of its Q2 2026 13F, Woodline Partners' AMLX position is worth $15.2M.

Question 4

Is Woodline Partners buying or selling AMLX?

Accepted Answer

In Q2 2026, Woodline Partners increased its AMLX position by 587 shares (+0.1%).

Question 5

When did Woodline Partners first buy AMLX?

Accepted Answer

Woodline Partners already held AMLX in its Q1 2022 13F, the earliest on record, and has listed it in 16 quarterly 13F filings.

Quarter	Action	Shares	Change	Value	Weight	Price	Conviction
2026-Q2 Latest	Increased	846,387	+0.1%	$15.2M	0.0%	$17.96	28
2026-Q1	Increased	845,800	+0.1%	$11.8M	0.0%	$14.11	28
2025-Q4	Increased	845,408	+0.0%	$10.2M	0.0%	$12.00	28
2025-Q3	Decreased	845,290	-29.6%	$11.5M	0.1%	$14.90	0
2025-Q2	Decreased	1.2M	-25.4%	$7.7M	0.0%	$6.33	0
2025-Q1	New	1.6M	—	$5.7M	0.0%	$3.66	37
2024-Q3	Exited	0	-100.0%	$0	0.0%	$3.08	0